Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UNITED THERAPEUTICS Corp Director's Dealing 2011

Feb 8, 2011

30320_dirs_2011-02-08_7d2e8436-6cc7-4d6c-8f8e-25f02dbfccca.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2011-02-07

Reporting Person: JEFFS ROGER (Director, President & COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-07 Common Stock M 10000 $25.315 Acquired 26120 Direct
2011-02-07 Common Stock S 10000 $65.95 Disposed 16120 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-07 Share Tracking Award $25.315 M 10000 Disposed 2018-06-03 Common Stock (10000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5942 Indirect

Footnotes

F1: Shares held by a family limited liability company of which the reporting person and his spouse are managing members.

F2: Exercise of a cash-settled share tracking award.

F3: Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.

F4: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.